-
1
-
-
84992343107
-
United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report
-
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute Atlanta
-
U.S. Cancer Statistics Working Group, United States Cancer Statistics: 1999–2013 Incidence and Mortality Web-based Report. 2016, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Atlanta www.cdc.gov/uscs.
-
(2016)
-
-
U.S. Cancer Statistics Working Group1
-
2
-
-
33645220428
-
Molecular profiling of platinum resistant ovarian cancer
-
Helleman, J., Jansen, M.P.H.M., Span, P.N., van Staveren, I.L., Massuger, L.F.A.G., Meijer-van Gelder, M.E., et al. Molecular profiling of platinum resistant ovarian cancer. Int. J. Cancer 118 (2005), 1963–1971.
-
(2005)
Int. J. Cancer
, vol.118
, pp. 1963-1971
-
-
Helleman, J.1
Jansen, M.P.H.M.2
Span, P.N.3
van Staveren, I.L.4
Massuger, L.F.A.G.5
Meijer-van Gelder, M.E.6
-
3
-
-
41349083323
-
Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
-
Itamochi, H., Kigawa, J., Terakawa, N., Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma. Cancer Sci. 99 (2008), 653–658.
-
(2008)
Cancer Sci.
, vol.99
, pp. 653-658
-
-
Itamochi, H.1
Kigawa, J.2
Terakawa, N.3
-
4
-
-
84940462511
-
New insights in the pathophysiology of ovarian cancer and implications for screening and prevention
-
Nezhat, F.R., Apostol, R., Nezhat, C., Pejovic, T., New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am. J. Obstet. Gynecol. 213 (2015), 262–267.
-
(2015)
Am. J. Obstet. Gynecol.
, vol.213
, pp. 262-267
-
-
Nezhat, F.R.1
Apostol, R.2
Nezhat, C.3
Pejovic, T.4
-
5
-
-
79955473637
-
Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010
-
Anglesio, M.S., Carey, M.S., Köbel, M., MacKay, H., Huntsman, D.G., Clear cell carcinoma of the ovary: a report from the first ovarian clear cell symposium, June 24th, 2010. Gynecol. Oncol. 121 (2011), 407–415.
-
(2011)
Gynecol. Oncol.
, vol.121
, pp. 407-415
-
-
Anglesio, M.S.1
Carey, M.S.2
Köbel, M.3
MacKay, H.4
Huntsman, D.G.5
-
6
-
-
84949684655
-
Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
-
Matsuzaki, S., Yoshino, K., Ueda, Y., Matsuzaki, S., Kakuda, M., Okazawa, A., et al. Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives. Cancer Cell Int., 15, 2015.
-
(2015)
Cancer Cell Int.
, vol.15
-
-
Matsuzaki, S.1
Yoshino, K.2
Ueda, Y.3
Matsuzaki, S.4
Kakuda, M.5
Okazawa, A.6
-
7
-
-
84867269276
-
Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma
-
Ayhan, A., Mao, T.-L., Seckin, T., Wu, C.-H., Guan, B., Ogawa, H., et al. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int. J. Gynecol. Cancer 22 (2012), 1310–1315.
-
(2012)
Int. J. Gynecol. Cancer
, vol.22
, pp. 1310-1315
-
-
Ayhan, A.1
Mao, T.-L.2
Seckin, T.3
Wu, C.-H.4
Guan, B.5
Ogawa, H.6
-
8
-
-
79959328816
-
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm
-
Kurman, R.J., Shih, I.M., Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum. Pathol. 42 (2011), 918–931.
-
(2011)
Hum. Pathol.
, vol.42
, pp. 918-931
-
-
Kurman, R.J.1
Shih, I.M.2
-
9
-
-
77957731999
-
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma
-
Jones, S., Wang, T.L., Shih, I.M., Mao, T.L., Nakayama, K., Roden, R., et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330 (2010), 228–231.
-
(2010)
Science
, vol.330
, pp. 228-231
-
-
Jones, S.1
Wang, T.L.2
Shih, I.M.3
Mao, T.L.4
Nakayama, K.5
Roden, R.6
-
10
-
-
77957946398
-
ARID1A mutations in endometriosis-associated ovarian carcinomas
-
Wiegand, K.C., Shah, S.P., Al-Agha, O.M., Zhao, Y., Tse, K., Zeng, T., et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363 (2010), 1532–1543.
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 1532-1543
-
-
Wiegand, K.C.1
Shah, S.P.2
Al-Agha, O.M.3
Zhao, Y.4
Tse, K.5
Zeng, T.6
-
11
-
-
79953797962
-
Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma
-
Guan, B., Mao, T.-L., Panuganti, P.K., Kuhn, E., Kurman, R.J., Maeda, D., et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am. J. Surg. Pathol. 35 (2011), 625–632.
-
(2011)
Am. J. Surg. Pathol.
, vol.35
, pp. 625-632
-
-
Guan, B.1
Mao, T.-L.2
Panuganti, P.K.3
Kuhn, E.4
Kurman, R.J.5
Maeda, D.6
-
12
-
-
79958238185
-
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
-
Wiegand, K.C., Lee, A.F., Al-Agha, O.M., Chow, C., Kalloger, S.E., Scott, D.W., et al. Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J. Pathol. 224 (2011), 328–333.
-
(2011)
J. Pathol.
, vol.224
, pp. 328-333
-
-
Wiegand, K.C.1
Lee, A.F.2
Al-Agha, O.M.3
Chow, C.4
Kalloger, S.E.5
Scott, D.W.6
-
13
-
-
84859162183
-
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
-
Pearce, C.L., Templeman, C., Rossing, M.A., Lee, A., Near, A.M., Webb, P.M., et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 13 (2012), 385–394.
-
(2012)
Lancet Oncol.
, vol.13
, pp. 385-394
-
-
Pearce, C.L.1
Templeman, C.2
Rossing, M.A.3
Lee, A.4
Near, A.M.5
Webb, P.M.6
-
14
-
-
84859427109
-
Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations
-
Yamamoto, S., Tsuda, H., Takano, M., Tamai, S., Matsubara, O., Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod. Pathol. 25 (2011), 615–624.
-
(2011)
Mod. Pathol.
, vol.25
, pp. 615-624
-
-
Yamamoto, S.1
Tsuda, H.2
Takano, M.3
Tamai, S.4
Matsubara, O.5
-
15
-
-
84866024623
-
Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma
-
Xiao, W., Awadallah, A., Xin, W., Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma. Int. J. Clin. Exp. Pathol. 5 (2012), 642–650.
-
(2012)
Int. J. Clin. Exp. Pathol.
, vol.5
, pp. 642-650
-
-
Xiao, W.1
Awadallah, A.2
Xin, W.3
-
16
-
-
80155131218
-
ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers
-
Guan, B., Wang, T.L., Shih, I.M., ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res. 71 (2011), 6718–6727.
-
(2011)
Cancer Res.
, vol.71
, pp. 6718-6727
-
-
Guan, B.1
Wang, T.L.2
Shih, I.M.3
-
17
-
-
84899070616
-
Novel three-dimensional in vitro models of ovarian endometriosis
-
Brueggmann, D., Templeman, C., Starzinski-Powitz, A., Rao, N.P., Gayther, S.A., Lawrenson, K., Novel three-dimensional in vitro models of ovarian endometriosis. J. Ovarian Res., 7, 2014, 17.
-
(2014)
J. Ovarian Res.
, vol.7
, pp. 17
-
-
Brueggmann, D.1
Templeman, C.2
Starzinski-Powitz, A.3
Rao, N.P.4
Gayther, S.A.5
Lawrenson, K.6
-
18
-
-
84908022645
-
Src as a novel therapeutic target for endometriosis
-
Lawrenson, K., Lee, N., Torres, H.A.M., Lee, J.M., Brueggmann, D., Rao, P.N., et al. Src as a novel therapeutic target for endometriosis. Gynecol. Oncol. 135 (2014), 100–107.
-
(2014)
Gynecol. Oncol.
, vol.135
, pp. 100-107
-
-
Lawrenson, K.1
Lee, N.2
Torres, H.A.M.3
Lee, J.M.4
Brueggmann, D.5
Rao, P.N.6
-
19
-
-
84992327282
-
DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells
-
Duymich, C.E., Charlet, J., Yang, X., Jones, P.A., Liang, G., DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells. Nat. Commun., 7, 2016, 11453.
-
(2016)
Nat. Commun.
, vol.7
, pp. 11453
-
-
Duymich, C.E.1
Charlet, J.2
Yang, X.3
Jones, P.A.4
Liang, G.5
-
20
-
-
84946221310
-
CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants
-
Spisák, S., Lawrenson, K., Fu, Y., Csabai, I., Cottman, R.T., Seo, J.H., et al., G.-O.E. Consortium. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants. Nat. Med. 21 (2015), 1357–1363.
-
(2015)
Nat. Med.
, vol.21
, pp. 1357-1363
-
-
Spisák, S.1
Lawrenson, K.2
Fu, Y.3
Csabai, I.4
Cottman, R.T.5
Seo, J.H.6
-
21
-
-
84870552401
-
Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules
-
Kelly, T.K., Liu, Y., Lay, F.D., Liang, G., Berman, B.P., Jones, P.A., Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res. 22 (2012), 2497–2506.
-
(2012)
Genome Res.
, vol.22
, pp. 2497-2506
-
-
Kelly, T.K.1
Liu, Y.2
Lay, F.D.3
Liang, G.4
Berman, B.P.5
Jones, P.A.6
-
22
-
-
84927704067
-
The role of DNA methylation in directing the functional organization of the cancer epigenome
-
Lay, F.D., Liu, Y., Kelly, T.K., Witt, H., Farnham, P.J., Jones, P.A., et al. The role of DNA methylation in directing the functional organization of the cancer epigenome. Genome Res. 25 (2015), 467–477.
-
(2015)
Genome Res.
, vol.25
, pp. 467-477
-
-
Lay, F.D.1
Liu, Y.2
Kelly, T.K.3
Witt, H.4
Farnham, P.J.5
Jones, P.A.6
-
23
-
-
84907997839
-
Gene body methylation can alter gene expression and is a therapeutic target in cancer
-
Yang, X., Han, H., De Carvalho, Daniel D., Lay, Fides D., Jones, Peter A., Liang, G., Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 26 (2014), 577–590.
-
(2014)
Cancer Cell
, vol.26
, pp. 577-590
-
-
Yang, X.1
Han, H.2
De Carvalho, D.D.3
Lay, F.D.4
Jones, P.A.5
Liang, G.6
-
24
-
-
53849146020
-
Model-based analysis of ChIP-seq (MACS)
-
Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., et al. Model-based analysis of ChIP-seq (MACS). Genome Biol., 9, 2008, R137.
-
(2008)
Genome Biol.
, vol.9
, pp. R137
-
-
Zhang, Y.1
Liu, T.2
Meyer, C.A.3
Eeckhoute, J.4
Johnson, D.S.5
Bernstein, B.E.6
-
25
-
-
84876836223
-
Modification of enhancer chromatin: what, how, and why?
-
Calo, E., Wysocka, J., Modification of enhancer chromatin: what, how, and why?. Mol. Cell 49 (2013), 825–837.
-
(2013)
Mol. Cell
, vol.49
, pp. 825-837
-
-
Calo, E.1
Wysocka, J.2
-
26
-
-
84966680811
-
Bivalent regions of cytosine methylation and H3K27 acetylation suggest an active role for DNA methylation at enhancers
-
Charlet, J., Duymich, Christopher E., Lay, Fides D., Mundbjerg, K., Dalsgaard Sørensen, K., Liang, G., et al. Bivalent regions of cytosine methylation and H3K27 acetylation suggest an active role for DNA methylation at enhancers. Mol. Cell 62 (2016), 422–431.
-
(2016)
Mol. Cell
, vol.62
, pp. 422-431
-
-
Charlet, J.1
Duymich, C.E.2
Lay, F.D.3
Mundbjerg, K.4
Dalsgaard Sørensen, K.5
Liang, G.6
-
27
-
-
34547624303
-
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
-
Mikkelsen, T.S., Ku, M., Jaffe, D.B., Issac, B., Lieberman, E., Giannoukos, G., et al. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448 (2007), 553–560.
-
(2007)
Nature
, vol.448
, pp. 553-560
-
-
Mikkelsen, T.S.1
Ku, M.2
Jaffe, D.B.3
Issac, B.4
Lieberman, E.5
Giannoukos, G.6
-
28
-
-
84862908850
-
Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation
-
Li, G., Ruan, X., Auerbach, Raymond K., Sandhu, Kuljeet S., Zheng, M., Wang, P., et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148 (2012), 84–98.
-
(2012)
Cell
, vol.148
, pp. 84-98
-
-
Li, G.1
Ruan, X.2
Auerbach, R.K.3
Sandhu, K.S.4
Zheng, M.5
Wang, P.6
-
29
-
-
84938923353
-
Inferring regulatory element landscapes and transcription factor networks from cancer methylomes
-
Yao, L., Shen, H., Laird, P.W., Farnham, P.J., Berman, B.P., Inferring regulatory element landscapes and transcription factor networks from cancer methylomes. Genome Biol., 16, 2015.
-
(2015)
Genome Biol.
, vol.16
-
-
Yao, L.1
Shen, H.2
Laird, P.W.3
Farnham, P.J.4
Berman, B.P.5
-
30
-
-
84943987463
-
Multiple comparisons among means
-
Dunn, O., Multiple comparisons among means. J. Am. Stat. Assoc. 56 (1961), 52–64.
-
(1961)
J. Am. Stat. Assoc.
, vol.56
, pp. 52-64
-
-
Dunn, O.1
-
31
-
-
34548459014
-
Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy
-
Cornelio, D.B., Roesler, R., Schwartsmann, G., Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann. Oncol. 18 (2007), 1457–1466.
-
(2007)
Ann. Oncol.
, vol.18
, pp. 1457-1466
-
-
Cornelio, D.B.1
Roesler, R.2
Schwartsmann, G.3
-
32
-
-
84905735682
-
Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer
-
He, X., Khurana, A., Roy, D., Kaufmann, S., Shridhar, V., Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer. Int. J. Cancer 135 (2014), 1783–1789.
-
(2014)
Int. J. Cancer
, vol.135
, pp. 1783-1789
-
-
He, X.1
Khurana, A.2
Roy, D.3
Kaufmann, S.4
Shridhar, V.5
-
33
-
-
0029055784
-
Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase
-
Hildebrand, J.D., Schaller, M.D., Parsons, J.T., Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol. Biol. Cell 6 (1995), 637–647.
-
(1995)
Mol. Biol. Cell
, vol.6
, pp. 637-647
-
-
Hildebrand, J.D.1
Schaller, M.D.2
Parsons, J.T.3
-
34
-
-
17344362877
-
Signaling by integrin receptors
-
Kumar, C.C., Signaling by integrin receptors. Oncogene 17 (1998), 1365–1373.
-
(1998)
Oncogene
, vol.17
, pp. 1365-1373
-
-
Kumar, C.C.1
-
35
-
-
84899563093
-
RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells
-
Fu, L., Zhang, S., RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells. Int. J. Mol. Med., 2014.
-
(2014)
Int. J. Mol. Med.
-
-
Fu, L.1
Zhang, S.2
-
36
-
-
42549156263
-
PDGF BB induces VEGF secretion in ovarian cancer
-
Matei, D., Kelich, S., Cao, L., Menning, N., Emerson, R.E., Rao, J., et al. PDGF BB induces VEGF secretion in ovarian cancer. Cancer Biol. Ther. 6 (2007), 1951–1959.
-
(2007)
Cancer Biol. Ther.
, vol.6
, pp. 1951-1959
-
-
Matei, D.1
Kelich, S.2
Cao, L.3
Menning, N.4
Emerson, R.E.5
Rao, J.6
-
37
-
-
0344237221
-
Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and -independent growth in human ovarian surface epithelial cell lines
-
Tashiro, H., Katabuchi, H., Begum, M., Li, X., Nitta, M., Ohtake, H., et al. Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and -independent growth in human ovarian surface epithelial cell lines. Cancer Sci. 94 (2003), 953–959.
-
(2003)
Cancer Sci.
, vol.94
, pp. 953-959
-
-
Tashiro, H.1
Katabuchi, H.2
Begum, M.3
Li, X.4
Nitta, M.5
Ohtake, H.6
-
38
-
-
84971238313
-
TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
-
Gupta, M., Babic, A., Beck, A.H., Terry, K., TNF-α expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?. Hum. Pathol. 54 (2016), 82–91.
-
(2016)
Hum. Pathol.
, vol.54
, pp. 82-91
-
-
Gupta, M.1
Babic, A.2
Beck, A.H.3
Terry, K.4
-
39
-
-
83255188897
-
Polycomb-repressed genes have permissive enhancers that initiate reprogramming
-
Taberlay, Phillippa C., Kelly, Theresa K., Liu, C.-C., You, Jueng S., De Carvalho, Daniel D., Miranda, Tina B., et al. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell 147 (2011), 1283–1294.
-
(2011)
Cell
, vol.147
, pp. 1283-1294
-
-
Taberlay, P.C.1
Kelly, T.K.2
Liu, C.-C.3
You, J.S.4
De Carvalho, D.D.5
Miranda, T.B.6
-
40
-
-
77952414230
-
Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET Oncogene in bladders with cancer
-
Wolff, E.M., Byun, H.-M., Han, H.F., Sharma, S., Nichols, P.W., Siegmund, K.D., et al. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET Oncogene in bladders with cancer. PLoS Genet., 6, 2010, e1000917.
-
(2010)
PLoS Genet.
, vol.6
, pp. e1000917
-
-
Wolff, E.M.1
Byun, H.-M.2
Han, H.F.3
Sharma, S.4
Nichols, P.W.5
Siegmund, K.D.6
-
41
-
-
84925502851
-
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
-
Bitler, B.G., Aird, K.M., Garipov, A., Li, H., Amatangelo, M., Kossenkov, A.V., et al. Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers. Nat. Med., 2015.
-
(2015)
Nat. Med.
-
-
Bitler, B.G.1
Aird, K.M.2
Garipov, A.3
Li, H.4
Amatangelo, M.5
Kossenkov, A.V.6
-
42
-
-
84949551829
-
SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2
-
Kim, K.H., Kim, W., Howard, T.P., Vazquez, F., Tsherniak, A., Wu, J.N., et al. SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2. Nat. Med. 21 (2015), 1491–1496.
-
(2015)
Nat. Med.
, vol.21
, pp. 1491-1496
-
-
Kim, K.H.1
Kim, W.2
Howard, T.P.3
Vazquez, F.4
Tsherniak, A.5
Wu, J.N.6
-
43
-
-
84962921733
-
Suppression of the SWI/SNF component ARID1A promotes mammalian regeneration
-
Sun, X., Chuang, J.-C., Kanchwala, M., Wu, L., Celen, C., Li, L., et al. Suppression of the SWI/SNF component ARID1A promotes mammalian regeneration. Cell Stem Cell 18 (2016), 456–466.
-
(2016)
Cell Stem Cell
, vol.18
, pp. 456-466
-
-
Sun, X.1
Chuang, J.-C.2
Kanchwala, M.3
Wu, L.4
Celen, C.5
Li, L.6
-
44
-
-
85003952292
-
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
-
Mathur, R., Alver, B.H., San Roman, A.K., Wilson, B.G., Wang, X., Agoston, A.T., et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat. Genet., 2016.
-
(2016)
Nat. Genet.
-
-
Mathur, R.1
Alver, B.H.2
San Roman, A.K.3
Wilson, B.G.4
Wang, X.5
Agoston, A.T.6
-
45
-
-
0016318441
-
Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium
-
Freedman, V., Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3 (1974), 355–359.
-
(1974)
Cell
, vol.3
, pp. 355-359
-
-
Freedman, V.1
-
46
-
-
68349125561
-
Anchorage-independent cell growth signature identifies tumors with metastatic potential
-
Mori, S., Chang, J.T., Andrechek, E.R., Matsumura, N., Baba, T., Yao, G., et al. Anchorage-independent cell growth signature identifies tumors with metastatic potential. Oncogene 28 (2009), 2796–2805.
-
(2009)
Oncogene
, vol.28
, pp. 2796-2805
-
-
Mori, S.1
Chang, J.T.2
Andrechek, E.R.3
Matsumura, N.4
Baba, T.5
Yao, G.6
-
47
-
-
1042267263
-
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
-
Cavallaro, U., Christofori, G., Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4 (2004), 118–132.
-
(2004)
Nat. Rev. Cancer
, vol.4
, pp. 118-132
-
-
Cavallaro, U.1
Christofori, G.2
-
48
-
-
66049088456
-
Combined integrin phosphoproteomic analyses and small interfering RNA-based functional screening identify key regulators for cancer cell adhesion and migration
-
Chen, Y., Lu, B., Yang, Q., Fearns, C., Yates, J.R., Lee, J.D., Combined integrin phosphoproteomic analyses and small interfering RNA-based functional screening identify key regulators for cancer cell adhesion and migration. Cancer Res. 69 (2009), 3713–3720.
-
(2009)
Cancer Res.
, vol.69
, pp. 3713-3720
-
-
Chen, Y.1
Lu, B.2
Yang, Q.3
Fearns, C.4
Yates, J.R.5
Lee, J.D.6
-
49
-
-
84953240912
-
Genome-wide transcriptional regulation mediated by biochemically distinct SWI/SNF complexes
-
Raab, J.R., Resnick, S., Magnuson, T., Genome-wide transcriptional regulation mediated by biochemically distinct SWI/SNF complexes. PLoS Genet., 11, 2015, e1005748.
-
(2015)
PLoS Genet.
, vol.11
, pp. e1005748
-
-
Raab, J.R.1
Resnick, S.2
Magnuson, T.3
-
50
-
-
84989853721
-
Loss of HDAC-mediated repression and gain of NF-κB activation underlie cytokine induction in ARID1A- and PIK3CA-mutation-driven ovarian cancer
-
Kim, M., Lu, F., Zhang, Y., Loss of HDAC-mediated repression and gain of NF-κB activation underlie cytokine induction in ARID1A- and PIK3CA-mutation-driven ovarian cancer. Cell Rep. 17 (2016), 275–288.
-
(2016)
Cell Rep.
, vol.17
, pp. 275-288
-
-
Kim, M.1
Lu, F.2
Zhang, Y.3
-
51
-
-
0034737290
-
Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
-
Zhang, H.S., Gavin, M., Dahiya, A., Postigo, A.A., Ma, D., Luo, R.X., et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101 (2000), 79–89.
-
(2000)
Cell
, vol.101
, pp. 79-89
-
-
Zhang, H.S.1
Gavin, M.2
Dahiya, A.3
Postigo, A.A.4
Ma, D.5
Luo, R.X.6
-
52
-
-
80455178817
-
Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms
-
Chatterjee, N., Sinha, D., Lemma-Dechassa, M., Tan, S., Shogren-Knaak, M.A., Bartholomew, B., Histone H3 tail acetylation modulates ATP-dependent remodeling through multiple mechanisms. Nucleic Acids Res. 39 (2011), 8378–8391.
-
(2011)
Nucleic Acids Res.
, vol.39
, pp. 8378-8391
-
-
Chatterjee, N.1
Sinha, D.2
Lemma-Dechassa, M.3
Tan, S.4
Shogren-Knaak, M.A.5
Bartholomew, B.6
-
53
-
-
32944462571
-
Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas
-
Hendrix, N.D., Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res. 66 (2006), 1354–1362.
-
(2006)
Cancer Res.
, vol.66
, pp. 1354-1362
-
-
Hendrix, N.D.1
|